A summary of the second MACR international scientific conference (2nd MSC)

• Main Authors: Chua, Eng Wee, Yong, Audrey Chee Hui, Ooi, Der Jiun, Lim, Jonathan Chee Woei, Foo, Jhi Biau, Gopal, Natesan, Lee, Sau Har, Wu, Yuan Seng *, Tan, Shing Cheng, Stanslas, Johnson
• Format: Article
• Published: Tech Science Press 2023
• Subjects: AS Academies and learned societies (General); RC Internal medicine
• Online Access: http://eprints.sunway.edu.my/2923/; https://doi.org/10.1515/oncologie-2023-0130

On 7th and 8th December 2022, with easing COVID-related restrictions, the 2nd MACR International Scientific Conference (2nd MSC) took place at the Bandar Saujana Putra Campus of MAHSA University, ensconced in a somewhat secluded part of Greater Kuala Lumpur, away from the downtown hubbub. The meeting is known for its specific focus on cancer-related research. The peace and quiet on campus were perhaps fitting for contemplation of the important question ‘Next-generation cancer therapeutics – Where are we heading?’. Over 200 attendees gathered at the university campus for the two-day conference, which was the fruit of collaboration between the Malaysian Association for Cancer Research (MACR), the Malaysian Oncological Society (MOS), and local public and private universities. The conference programme spanned a variety of cancer research areas i.e., identification of novel cancer drug targets, discovery of new cancer drugs, translational cancer medicine, clinical trials of new cancer drugs, diagnostic and prognostic values of new cancer markers, cancer prevention, and precision oncology. A total of 44 abstracts were accepted for presentation at the conference (22 posters, 22 oral presentations).